Step Change in Safe Harbors: Public–Private Partnerships

Abstract

This editorial cites SEMATECH, a company formed by collaboration between industry and government in the semiconductor manufacturing field, as an example of how the public and private sectors might begin to work together in the all-important area of biomarkers in cancer drug development.